A new scientific statement from the American Heart Association outlines maternal stroke risk and prevention and treatment strategies during pregnancy and postpartum.
Use of GLP-1s is linked to lower risk for subarachnoid hemorrhage and mortality in patients with intracranial aneurysms and type 2 diabetes compared to use of other agents, a new study shows.